Gilmer Daniel B.
SEC insider (Form 3/4/5 filer). CIK 0002122703. Director at Armata Pharmaceuticals, Inc. (ARMP). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 24, 2026. Located in LOS ANGELES, CA.
Companies Gilmer Daniel B. has filed insider reports for
- Armata Pharmaceuticals, Inc. (ARMP): Director
Gilmer Daniel B.
CIK: 0002122703
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARMP
Armata Pharmaceuticals, Inc.
Director